Multiple‐Dose Pharmacokinetics and Bioequivalence L-Carnitine 330-mg Tablet versus 1-g Chewable Tablet versus Enteral Solution in Healthy Adult Male Volunteers

This publication has 12 references indexed in Scilit:

• Comparison ofL‐Carnitine Pharmacokinetics With and Without Baseline Correction Following Administration of Single 20–mglkg Intravenous Dose
  Journal of Pharmaceutical Sciences, 1995
• Pharmacokinetics and safety of l-carnitine infused i. v. in healthy subjects
  European Journal of Clinical Pharmacology, 1988
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987
• l-Carnitine
  Drugs, 1987
• Successful Carnitine Treatment in Two Siblings Having Lipid Storage Myopathy with Hypertrophic Cardiomyopathy
  Neuropediatrics, 1985
• Fat metabolism following an intravenous bolus dose of a fat emulsion and carnitine
  Clinical Physiology and Functional Imaging, 1984
• Systemic carnitine deficiency
  Neurology, 1984
• The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis.
  Japanese Circulation Journal, 1983
• Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport
  The Journal of Pediatrics, 1982
• Primary systemic carnitine dehciency. II. Renal handling of carnitine
  Neurology, 1981